Trump Tariffs: Will They Work?
Could these stocks be long-term winners from President Trump's trade war? Our analysts have carefully selected companies that might benefit if Trump's tariff strategy delivers the manufacturing revival he's promising.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Unlock all stocks by downloading the app for FREE.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
President Trump has implemented widespread tariffs on imports from major trading partners like China, Europe, and Canada. This collection focuses on US companies that could benefit if these protectionist policies successfully reduce foreign competition and strengthen domestic manufacturing.
What You Need to Know
These tariffs represent the biggest shake-up to global trade in nearly a century. While they've initially caused market volatility, they could create opportunities for US companies in steel, aluminum, auto manufacturing, semiconductors, and retail with strong domestic supply chains.
Why These Stocks
We've handpicked companies across key sectors targeted by Trump's policy - from industrial manufacturers to technology firms. These selections represent businesses that might gain competitive advantages if the tariffs achieve their intended goals of reviving US manufacturing and employment.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+12.61%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 12.61% over the next year.
Stocks Rated Buy by Analysts
7 of 10 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 2.3% return last month.
Why You'll Want to Watch These Stocks
America's Manufacturing Revival
These companies could be at the forefront of a potential US manufacturing resurgence that hasn't been seen in decades. If Trump's tariff strategy works, they might be positioned for substantial growth.
Century-Defining Trade Shift
We're witnessing the biggest change to global trade policies since 1930. Getting in early on the right companies could mean capturing value from this historic economic realignment.
Potential Domestic Champions
With foreign competition potentially reduced, these American companies might gain market share and pricing power in their industries. They're selected from sectors specifically targeted for protection.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.